2021
DOI: 10.3892/mi.2021.25
|View full text |Cite
|
Sign up to set email alerts
|

Relapse of Graves' disease following SARS‑CoV‑2 infection: A case report and brief literature review

Abstract: The interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and autoimmune thyroid disease is an emerging phenomenon. The present study describes the case of a 28-year-old female who experienced a relapse of Graves' disease following SARS-CoV-2 infection. She was biochemically euthyroid for 2 years prior to COVID-19 infection. However, she began experiencing palpitations, increased sweating and tremors of the hands 9 days after being diagnosed with COVID-19-related pneumonia. In additi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…The vast spectrum of thyroid disorders proceeding the infection further highlights the many unknowns of SARS-CoV-2. When SARS-CoV-2 enters the host, it binds to angiotensin-converting enzyme 2 (ACE2) receptors via its spike protein [ 6 ]. Although ACE2 is most notably associated with lung tissue, many other human cells express it as well, including those in the pancreas, thyroid, testis, ovary, adrenal glands, and pituitary gland [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The vast spectrum of thyroid disorders proceeding the infection further highlights the many unknowns of SARS-CoV-2. When SARS-CoV-2 enters the host, it binds to angiotensin-converting enzyme 2 (ACE2) receptors via its spike protein [ 6 ]. Although ACE2 is most notably associated with lung tissue, many other human cells express it as well, including those in the pancreas, thyroid, testis, ovary, adrenal glands, and pituitary gland [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…Since the emergence of the COVID-19 pandemic, there has been a surge of reports linking the effects of SARS-CoV-2 infection with the development of various autoimmune diseases, including rheumatologic conditions [ 1 ], hematologic conditions [ 2 ], Guillain-Barré syndrome [ 3 ], and type 1 diabetes [ 4 ]. We are still elucidating the effects of SARS-CoV-2 on the thyroid gland, but several reports have demonstrated a spectrum of thyroid ailments, including Hashimoto disease, Graves’ disease (GD), postpartum thyroiditis, and subclinical thyroid abnormalities [ 5 , 6 ]. Patients with a history of thyroid disease or a genetic disposition can experience a more severe infection [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…An association between SARS-CoV-2 infection and autoimmune disease is increasingly described, with many reports of patients developing autoantibodies after COVID-19 [ 1 ] . Data on SARS-CoV-2 thyroid involvement is scarce, but there are reports of Graves' disease, Hashimoto's disease and postpartum thyroiditis subsequent to SARS-CoV-2 infection [ 2 , 3 ] .…”
Section: Discussionmentioning
confidence: 99%
“…Reported cases of Graves’ disease induced by SARS-CoV-2 may present as a new diagnosis or recurrence in patients with a history of the condition. In the majority of cases, symptoms presented within 2 months of infection [ 1 ] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation